Search

Search Constraints

You searched for: Author/Creator Fargion, S.

Search Results

11. Epicardial fat thickness is an ectopic fat associated with metabolic syndrome, subclinical atherosclerosis and markers of cardiac dysfunction in the general population. Issue 1 (July 2015)

12. Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group. Issue 1 (February 2018)

13. Excellent effectiveness of direct-acting antivirals for HCV treatment in patients with cirrhosis: Analysis of 3345 patients from the Lombardia Network. Issue 1 (February 2018)

14. Fibroscan liver stiffness (LMS) and controlled attenuation parameter (CAP) in the evaluation of cardiovascular risk assessment in patients with NAFLD. Issue 1 (February 2018)

15. FNDC5 rs3480 A>G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease. (10th February 2016)

16. Functional characterization of a novel genetic variant predisposing to hepatocellular carcinoma development in nonalcoholic fatty liver disease. Issue 1 (February 2018)

17. FXR rs35724 G>C variant modulates cholesterol levels, carotid atherosclerosis and liver damage in non-alcoholic fatty liver. (February 2019)

18. Genotype 3 infection in DAA era: Preliminary reports of a real life northern Italy network for viral hepatitis. (8th October 2016)

19. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study. (10th February 2016)

20. Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis. Issue 1 (February 2018)